Take a look at the Medicare reimbursement system, and you’ll see a potentially dark future if the government is able to negotiate drug prices:
As senators weigh the merits of such an approach, they should keep in mind that the Medicare physician payment system””a combination of administrative pricing and price controls””is a mess. It should serve as a warning. Administrative pricing for more than 7,000 physicians’ services has failed to reduce Medicare spending, lacks the proper incentives to promote value, and threatens personal choice and access to quality health care for America’s seniors. The maladies of this physician payment system should not be allowed to infect seniors’ access to drugs.
